162 related articles for article (PubMed ID: 16284376)
21. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
22. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.
Lin CJ; Lai HC; Wang KH; Hsiung CA; Liu HW; Ding DC; Hsieh CY; Chu TY
Am J Obstet Gynecol; 2011 Jan; 204(1):21.e1-7. PubMed ID: 20833385
[TBL] [Abstract][Full Text] [Related]
23. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
[TBL] [Abstract][Full Text] [Related]
24. High-risk human papillomavirus genotype distribution and attribution to cervical cancer and precancerous lesions in a rural Chinese population.
Zhao XL; Hu SY; Zhang Q; Dong L; Feng RM; Han R; Zhao FH
J Gynecol Oncol; 2017 Jul; 28(4):e30. PubMed ID: 28541628
[TBL] [Abstract][Full Text] [Related]
25. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
Syrjänen K; Shabalova I; Sarian L; Naud P; Longatto-Filho A; Derchain S; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Serpa Hammes L; Podistov J; Costa S; Syrjänen S; ;
Eur J Gynaecol Oncol; 2012; 33(1):5-14. PubMed ID: 22439398
[TBL] [Abstract][Full Text] [Related]
26. The clinical value of digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears.
Recio FO; Sahai Srivastava BI; Wong C; Hempling RE; Eltabbakh GH; Piver MS
Eur J Gynaecol Oncol; 1998; 19(3):203-8. PubMed ID: 9641214
[TBL] [Abstract][Full Text] [Related]
27. Detection of high-grade neoplasia in air-dried cervical PAP smears by a microRNA-based classifier.
Ivanov MK; Titov SE; Glushkov SA; Dzyubenko VV; Malek AV; Arkhangelskaya PA; Samsonov RB; Mikhetko AA; Bakhidze EV; Berlev IV; Kolesnikov NN
Oncol Rep; 2018 Mar; 39(3):1099-1111. PubMed ID: 29328473
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
[TBL] [Abstract][Full Text] [Related]
29. [Association between high-risk human papillomavirus DNA load and cervical intraepithelial lesion].
Zhao FH; Ma JF; Qiao YL; Rong SD; Li L; Zhang WH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Nov; 25(11):921-4. PubMed ID: 15769315
[TBL] [Abstract][Full Text] [Related]
30. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
31. Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study.
Xi LF; Hughes JP; Castle PE; Edelstein ZR; Wang C; Galloway DA; Koutsky LA; Kiviat NB; Schiffman M
J Infect Dis; 2011 May; 203(10):1425-33. PubMed ID: 21415020
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal expansion with integration of high-risk type human papillomaviruses is an initial step for cervical carcinogenesis: association of clonal status and human papillomavirus infection with clinical outcome in cervical intraepithelial neoplasia.
Ueda Y; Enomoto T; Miyatake T; Ozaki K; Yoshizaki T; Kanao H; Ueno Y; Nakashima R; Shroyer KR; Murata Y
Lab Invest; 2003 Oct; 83(10):1517-27. PubMed ID: 14563953
[TBL] [Abstract][Full Text] [Related]
33. Combined human papillomavirus DNA and human papillomavirus-like particle serologic assay to identify women at risk for high-grade cervical intraepithelial neoplasia.
Einstein MH; Studentsov YY; Ho GY; Fazzari M; Marks M; Kadish AS; Goldberg GL; Runowicz CD; Burk RD
Int J Cancer; 2007 Jan; 120(1):55-9. PubMed ID: 17036320
[TBL] [Abstract][Full Text] [Related]
34. Managing atypical squamous cells of undetermined significance in Papanicolaou smears.
Morin C; Bairati I; Bouchard C; Fortier M; Roy M; Moore L; Meisels A
J Reprod Med; 2001 Sep; 46(9):799-805. PubMed ID: 11584480
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
36. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).
Acladious NN; Sutton C; Mandal D; Hopkins R; Zaklama M; Kitchener H
Int J Cancer; 2002 Mar; 98(3):435-9. PubMed ID: 11920596
[TBL] [Abstract][Full Text] [Related]
37. The association between human papillomavirus 16, 18 DNA load and E6 protein expression in cervical intraepithelial neoplasia and cancer.
Wu Z; Yu L; Lei X; Qin Y; Zhang X; Chen W; Qiao Y
J Clin Virol; 2018 Nov; 108():6-11. PubMed ID: 30196013
[TBL] [Abstract][Full Text] [Related]
38. Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA-positive women with equivocal or mildly abnormal cytology.
McIntyre-Seltman K; Castle PE; Guido R; Schiffman M; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1165-70. PubMed ID: 15894667
[TBL] [Abstract][Full Text] [Related]
39. Differential viral loads of human papillomavirus 16 and 58 infections in the spectrum of cervical carcinogenesis.
Lai HC; Peng MY; Nieh S; Yu CP; Chang CC; Lin YW; Sun CA; Chu TY
Int J Gynecol Cancer; 2006; 16(2):730-5. PubMed ID: 16681753
[TBL] [Abstract][Full Text] [Related]
40. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
Dane C; Batmaz G; Dane B; Cetin A
Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
